Dishman Carbogen Amcis Intrinsic Value
Dishman Carbogen Amcis intrinsic value. Dishman Carbogen Amcis (DCAL) median intrinsic value is ₹303.00 from 8 valuation models (range ₹45–₹455), vs current price ₹151.50 — +100.0% upside (Trading Below Calculated Value), margin of safety 50.0%. Compare with Dishman Carbogen Amcis value estimation to assess whether the stock is under or overvalued.
DCAL Valuation Methods Summary — DCF, Graham Number & P/E
Dishman Carbogen Amcis intrinsic value across 8 models vs current price ₹151.50 — upside/downside and value range per method. For current market price and key ratios, visit Dishman Carbogen Amcis stock price NSE.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹122.32 | ₹97.86 - ₹146.78 | -19.3% | EPS: ₹5.56, Sector P/E: 22x |
| Book Value Method | asset | ₹378.75 | ₹340.88 - ₹416.63 | +150.0% | Book Value/Share: ₹2153.87, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹303.00 | ₹272.70 - ₹333.30 | +100.0% | Revenue/Share: ₹1120.00, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹303.00 | ₹272.70 - ₹333.30 | +100.0% | EBITDA: ₹712.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹378.75 | ₹303.00 - ₹454.50 | +150.0% | CF Growth: 8.5%, Discount: 15% |
| PEG Ratio Method | growth | ₹45.45 | ₹40.91 - ₹50.00 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹85.90 | ₹77.31 - ₹94.49 | -43.3% | Revenue Growth: 6.0%, Adj P/E: 15.5x |
| Graham Defensive Method | conservative | ₹454.50 | ₹409.05 - ₹499.95 | +200.0% | EPS: ₹5.56, BVPS: ₹2153.87 |
DCAL Intrinsic Value vs Market Price — All Valuation Models
Dishman Carbogen Amcis fair value range ₹45–₹455 vs current market price ₹151.50 across 8 valuation models. Read Dishman Carbogen Amcis dividend payments for the complete payout history and dividend yield track record.
DCAL Intrinsic Value Analysis — Undervalued or Overvalued?
Dishman Carbogen Amcis median intrinsic value ₹303.00, current price ₹151.50 — Trading Below Calculated Value by 100.0%, margin of safety 50.0%.
What is the intrinsic value of DCAL?
Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Dishman Carbogen Amcis (DCAL) is ₹303.00 (median value). With the current market price of ₹151.50, this represents a +100.0% variance from our estimated fair value.
The valuation range spans from ₹45.45 to ₹454.50, indicating ₹45.45 - ₹454.50.
Is DCAL undervalued or overvalued?
Based on our multi-method analysis, Dishman Carbogen Amcis (DCAL) appears to be trading below calculated value by approximately 100.0%.
DCAL Financial Health — Key Ratios vs Industry Benchmarks
Dishman Carbogen Amcis financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 0.97 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Return on Equity | 1.3% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 19.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.29x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
DCAL Cash Flow Quality — Operating & Free Cash Flow
Dishman Carbogen Amcis operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹492 Cr | ₹370 Cr | Positive Free Cash Flow | 8/10 |
| March 2025 | ₹371 Cr | ₹275 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹379 Cr | ₹267 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹266 Cr | ₹19 Cr | Positive Free Cash Flow | 7/10 |
| March 2022 | ₹355 Cr | ₹46 Cr | Positive Free Cash Flow | 7/10 |